Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+23.4%
5Y CAGR+5.7%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+23.4%/yr
vs +14.7%/yr prior
5Y CAGR
+5.7%/yr
Recent acceleration
Acceleration
+8.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $465.89M | +35.5% |
| 2024 | $343.82M | +67.1% |
| 2023 | $205.80M | -17.0% |
| 2022 | $247.94M | -35.0% |
| 2021 | $381.59M | +8.0% |
| 2020 | $353.26M | +64.7% |
| 2019 | $214.45M | +49.5% |
| 2018 | $143.45M | -48.4% |
| 2017 | $277.83M | +13.3% |
| 2016 | $245.21M | - |